Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1264-1267

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoorntje, T.
Right arrow Articles by Wilde, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoorntje, T.
Right arrow Articles by Wilde, A.
Related Collections
Right arrow Clinical genetics
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 1999;100:1264-1267.)
© 1999 American Heart Association, Inc.


Brief Rapid Communication

Homozygous Premature Truncation of the HERG Protein

The Human HERG Knockout

Theo Hoorntje, MD; Marielle Alders, PhD; Peter van Tintelen, MD; Karin van der Lip; Narayanswami Sreeram, MD; Allard van der Wal, MD; Marcel Mannens, PhD; Arthur Wilde, MD

From the Departments of Pediatric Cardiology, University Hospital and Wilhelmina Children's Hospital (T.H., N.S.), Utrecht; the Departments of Clinical Genetics (M.A., K.v.d.L., M.M.), Cardiovascular Pathology (A.v.d.W.), and Clinical and Experimental Cardiology (A.W.), Academic Medical Center, Amsterdam; and the Departments of Medical Genetics (P.v.T.) and Cardiology (A.W.), University Medical Centre Utrecht, Utrecht; and The Interuniversity Cardiology Institute, The Netherlands.

Correspondence to Dr Wilde, Department of Clinical and Experimental Cardiology, AMC Amsterdam, PO BOX 22700, 1100 DE Amsterdam, the Netherlands. E-mail a.a.wilde{at}AMC.UVA.NL

Background—In long-QT syndrome (LQTS), heterozygosity for a mutation in 1 of the K+ channel genes leads to prolongation of the cardiac action potential, because the aberrant protein exhibits "loss of function." HERG, which is involved in LQT2, is the gene encoding the rapid component of the delayed rectifier, IKr.

Methods and Results—In a consanguineous family, a stillbirth was followed by the premature birth of a child in distress due to ventricular arrhythmia in the presence of QT prolongation. LQTS was diagnosed, ß-blocker therapy was begun, and a pacemaker was implanted. She developed well and remained symptom-free for 1.5 years. In the index patient, we identified a duplication of bp 558 to 600 in exon 4 of HERG on both alleles. This will result in a frameshift and a premature stop codon before the S1 domain of the HERG protein. Because it is present on both alleles, no functional IKr is anticipated. The same mutation was found heterozygously in both parents and homozygously in the stillborn brother.

Conclusions—It is concluded that absence of IKr gives rise to a severe cardiac phenotype, with no indication of malfunction of any other organ.


Key Words: genetics • torsade de pointes • arrhythmia




This article has been cited by other articles:


Home page
Circ. Res.Home page
G. Q. Teng, X. Zhao, J. P. Lees-Miller, F. R. Quinn, P. Li, D. E. Rancourt, B. London, J. C. Cross, and H. J. Duff
Homozygous Missense N629D hERG (KCNH2) Potassium Channel Mutation Causes Developmental Defects in the Right Ventricle and Its Outflow Tract and Embryonic Lethality
Circ. Res., December 5, 2008; 103(12): 1483 - 1491.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. T. Clusin
Mechanisms of calcium transient and action potential alternans in cardiac cells and tissues
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H1 - H10.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Medeiros-Domingo, T. Kaku, D. J. Tester, P. Iturralde-Torres, A. Itty, B. Ye, C. Valdivia, K. Ueda, S. Canizales-Quinteros, M. T. Tusie-Luna, et al.
SCN4B-Encoded Sodium Channel 4 Subunit in Congenital Long-QT Syndrome
Circulation, July 10, 2007; 116(2): 134 - 142.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Arnaout, T. Ferrer, J. Huisken, K. Spitzer, D. Y. R. Stainier, M. Tristani-Firouzi, and N. C. Chi
Zebrafish model for human long QT syndrome
PNAS, July 3, 2007; 104(27): 11316 - 11321.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. J. Heradien, A. Goosen, L. Crotti, G. Durrheim, V. Corfield, P. A. Brink, and P. J. Schwartz
Does Pregnancy Increase Cardiac Risk for LQT1 Patients With the KCNQ1-A341V Mutation?
J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1410 - 1415.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Kaab and E. Schulze-Bahr
Susceptibility genes and modifiers for cardiac arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 397 - 413.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Milan and C. A. MacRae
Animal models for arrhythmias
Cardiovasc Res, August 15, 2005; 67(3): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
Recurrent syncope
Postgrad. Med. J., March 1, 2005; 81(953): 202 - 202.
[Full Text] [PDF]


Home page
EuropaceHome page
A. D.J. Ten Harkel, M. Witsenburg, P. L. de Jong, L. Jordaens, M. Wijman, and A. A.M. Wilde
Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias
Europace, January 1, 2005; 7(1): 77 - 84.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. P. McNair, L. Ku, M. R.G. Taylor, P. R. Fain, D. Dao, E. Wolfel, L. Mestroni, and the Familial Cardiomyopathy Registry Research Grou
SCN5A Mutation Associated With Dilated Cardiomyopathy, Conduction Disorder, and Arrhythmia
Circulation, October 12, 2004; 110(15): 2163 - 2167.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. J. Schwartz
Stillbirths, Sudden Infant Deaths, and Long-QT Syndrome: Puzzle or Mosaic, the Pieces of the Jigsaw Are Being Fitted Together
Circulation, June 22, 2004; 109(24): 2930 - 2932.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. S. Chugh, O. Senashova, A. Watts, P. T. Tran, Z. Zhou, Q. Gong, J. L. Titus, and S. J. Hayflick
Postmortem molecular screening in unexplained sudden death
J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1625 - 1629.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J.-M. Lupoglazoff, I. Denjoy, E. Villain, V. Fressart, F. Simon, A. Bozio, M. Berthet, N. Benammar, B. Hainque, and P. Guicheney
Long QT syndrome in neonates: Conduction disorders associated with HERG mutations and sinus bradycardia with KCNQ1 mutations
J. Am. Coll. Cardiol., March 3, 2004; 43(5): 826 - 830.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. P. Lees-Miller, J. Guo, J. R. Somers, D. E. Roach, R. S. Sheldon, D. E. Rancourt, and H. J. Duff
Selective Knockout of Mouse ERG1 B Potassium Channel Eliminates IKr in Adult Ventricular Myocytes and Elicits Episodes of Abrupt Sinus Bradycardia
Mol. Cell. Biol., March 15, 2003; 23(6): 1856 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. R. Bezzina, M. B. Rook, W.A. Groenewegen, L. J. Herfst, A. C. van der Wal, J. Lam, H. J. Jongsma, A. A.M. Wilde, and M. M.A.M. Mannens
Compound Heterozygosity for Mutations (W156X and R225W) in SCN5A Associated With Severe Cardiac Conduction Disturbances and Degenerative Changes in the Conduction System
Circ. Res., February 7, 2003; 92(2): 159 - 168.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. R Bezzina and H. L Tan
Pharmacological rescue of mutant ion channels
Cardiovasc Res, August 1, 2002; 55(2): 229 - 232.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J.M. Lupoglazoff, T. Cheav, G. Baroudi, M. Berthet, I. Denjoy, B. Cauchemez, F. Extramiana, M. Chahine, and P. Guicheney
Homozygous SCN5A Mutation in Long-QT Syndrome With Functional Two-to-One Atrioventricular Block
Circ. Res., July 20, 2001; 89 (2): e16 - e21.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. E. Clancy and Y. Rudy
Cellular consequences of HERG mutations in the long QT syndrome: precursors to sudden cardiac death
Cardiovasc Res, May 1, 2001; 50(2): 301 - 313.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. Thomas, G. Wendt-Nordahl, K. Röckl, E. Ficker, A. M. Brown, and J. Kiehn
High-Affinity Blockade of Human Ether-A-Go-Go-Related Gene Human Cardiac Potassium Channels by the Novel Antiarrhythmic Drug BRL-32872
J. Pharmacol. Exp. Ther., April 12, 2001; 297(2): 753 - 761.
[Abstract] [Full Text]


Home page
CirculationHome page
B. London, A. A.M. Wilde, M. M.A.M. Mannens, M. Alders, K. van der Lip, T. M. Hoorntje, N. Sreeram, P. van Tintelen, and A. van der Wal
A Knockout May Not Always Be a Knockout Response
Circulation, October 31, 2000; 102 (18): e122 - e122.
[Full Text] [PDF]


Home page
CirculationHome page
I. Splawski, J. Shen, K. W. Timothy, M. H. Lehmann, S. Priori, J. L. Robinson, A. J. Moss, P. J. Schwartz, J. A. Towbin, G. M. Vincent, et al.
Spectrum of Mutations in Long-QT Syndrome Genes : KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
Circulation, September 5, 2000; 102(10): 1178 - 1185.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C.-E. Chiang and D. M. Roden
The long QT syndromes: genetic basis and clinical implications
J. Am. Coll. Cardiol., July 1, 2000; 36(1): 1 - 12.
[Abstract] [Full Text] [PDF]